An adaptable research platform for ex vivo normothermic machine perfusion of the liver

被引:1
|
作者
Magbagbeola, M. [1 ]
Rai, Z. L. [1 ,2 ,3 ]
Doyle, K. [1 ]
Lindenroth, L. [4 ]
Dwyer, G. [1 ]
Gander, A. [2 ,3 ]
Stilli, A. [1 ]
Davidson, B. R. [1 ,2 ,3 ]
Stoyanov, D. [1 ]
机构
[1] UCL, Wellcome EPSRC Ctr Intervent & Surg Sci WEISS, London, England
[2] UCL, Ctr Surg Innovat, London, England
[3] Royal Free Hosp NHS Trust, London, England
[4] Kings Coll London, Sch Biomed Engn & Imaging Sci, Dept Surg & Intervent Engn, London, England
基金
英国工程与自然科学研究理事会;
关键词
Liver preservation; Systems design; Machine perfusion; PRESSURE;
D O I
10.1007/s11548-023-02903-4
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
PurposeThis paper presents an assessment of a low-cost organ perfusion machine designed for use in research settings. The machine is modular and versatile in nature, built on a robotic operating system (ROS2) pipeline allowing for the addition of specific sensors for different research applications. Here we present the system and the development stages to achieve viability of the perfused organ.MethodsThe machine's perfusion efficacy was assessed by monitoring the distribution of perfusate in livers using methylene blue dye. Functionality was evaluated by measuring bile production after 90 min of normothermic perfusion, while viability was examined using aspartate transaminase assays to monitor cell damage throughout the perfusion. Additionally, the output of the pressure, flow, temperature, and oxygen sensors was monitored and recorded to track the health of the organ during perfusion and assess the system's capability of maintaining the quality of data over time.ResultsThe results show the system is capable of successfully perfusing porcine livers for up to three hours. Functionality and viability assessments show no deterioration of liver cells once normothermic perfusion had occurred and bile production was within normal limits of approximately 26 ml in 90 min showing viability.ConclusionThe developed low-cost perfusion system presented here has been shown to keep porcine livers viable and functional ex vivo. Additionally, the system is capable of easily incorporating several sensors into its framework and simultaneously monitor and record them during perfusion. The work promotes further exploration of the system in different research domains.
引用
收藏
页码:1101 / 1108
页数:8
相关论文
共 50 条
  • [31] Assessing Discarded Human Liver Quality with Normothermic Ex-Vivo Liver Perfusion
    Zhou, F.
    Xu, M.
    Garcia-Aroz, S.
    Upadhya, G. A.
    Lin, Y.
    Chapman, W. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1126 - 1126
  • [32] Normothermic Ex Vivo Heart Perfusion in Argentina
    Berra, I. G.
    Berra, S.
    Berra, M. L.
    Irusta, A.
    Lewis, M. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S222 - S223
  • [33] Normothermic Perfusion of Extended Criteria Donor Kidneys Utilizing an Ex Vivo Machine
    Hossain, M. A.
    Bagul, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (09) : 2501 - 2502
  • [34] OUTCOMES OF LIVER TRANSPLANTATION WITH SEQUENTIAL IN-SITU NORMOTHERMIC REGIONAL PERFUSION AND EX-SITU NORMOTHERMIC MACHINE PERFUSION
    Paul, Subhankar
    Butler, Andrew
    Watson, Christopher
    Swift, Lisa
    Fear, Corrina
    Webster, Rachel
    Gaurav, Rohit
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (01) : S95 - S95
  • [35] Observations and findings during the development of a subnormothermic/normothermic long-term ex vivo liver perfusion machine
    Schuler, Martin J.
    Becker, Dustin
    Mueller, Matteo
    Bautista Borrego, Lucia
    Mancina, Leandro
    Huwyler, Florian
    Binz, Jonas
    Hagedorn, Catherine
    Schaer, Beatrice
    Gygax, Erich
    Weisskopf, Miriam
    Sousa Da Silva, Richard Xavier
    Antunes Crisostomo, Joao Miguel
    Dutkowski, Philipp
    Rudolf von Rohr, Philipp
    Clavien, Pierre-Alain
    Tibbitt, Mark W.
    Eshmuminov, Dilmurodjon
    Hefti, Max
    ARTIFICIAL ORGANS, 2023, 47 (02) : 317 - 329
  • [36] Revolutionizing TPA administration: treating DCD liver grafts during ex-vivo normothermic machine perfusion
    Todd, R.
    Rosowicz, A.
    Van Leeuwen, L.
    Arvelakis, A.
    DiNorcia, J.
    Rocha, C.
    Tabrizian, P.
    Facciuto, M.
    Schwartz, M.
    Moon, J.
    Schiano, T.
    Kim-Schluger, L.
    Akhtar, M. Z.
    Florman, S.
    LIVER TRANSPLANTATION, 2024, 30 : 188 - 188
  • [37] Comparison of BQ123, Epoprostenol, and Verapamil as Vasodilators During Normothermic Ex Vivo Liver Machine Perfusion
    Echeverri, Juan
    Goldaracena, Nicolas
    Kaths, Johan Moritz
    Linares, Ivan
    Roizales, Roizar
    Kollmann, Dagmar
    Hamar, Matyas
    Urbanellis, Peter
    Ganesh, Sujani
    Adeyi, Oyedele A.
    Tazari, Mahmood
    Selzner, Markus
    Selzner, Nazia
    TRANSPLANTATION, 2018, 102 (04) : 601 - 608
  • [38] Preliminary Observations of An Ex Vivo Normothermic Whole Blood Machine Perfusion in An Experimental Liver Transplant Porcine Model
    Yoshimoto, Syuhei
    Soyama, Akihiko
    Fukumoto, Masayuki
    Hara, Takanobu
    Hidaka, Masaaki
    Torai, Shinji
    Kasamatsu, Hiroo
    Ishikawa, Jun
    Ohara, Masayuki
    Kobayashi, Eiji
    Eguchi, Susumu
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (04) : 1005 - 1011
  • [39] Improvement of Normothermic Ex Vivo Machine Perfusion of Rat Liver Grafts by Dialysis and Kupffer Cell Inhibition With Glycine
    Gassner, Joseph M. G. V.
    Noesser, Maximilian
    Moosburner, Simon
    Horner, Rosa
    Tang, Peter
    Wegener, Lara
    Wyrwal, David
    Claussen, Felix
    Arsenic, Ruza
    Pratschke, Johann
    Sauer, Igor M.
    Raschzok, Nathanael
    LIVER TRANSPLANTATION, 2019, 25 (02) : 275 - 287
  • [40] DEVELOPMENT AND EVALUATION OF A DUAL-VESSEL NORMOTHERMIC EX VIVO MACHINE PERFUSION MODEL FOR RAT LIVER GRAFTS
    Felix, C.
    Joseph, G.
    David, W.
    Simon, M.
    Maximilian, N.
    Johann, P.
    Igor, S.
    Nathanael, R.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 268 - 268